Cargando…
Overexpression of CXXC5 is a strong poor prognostic factor in ER+ breast cancer
CXXC5 is a newly identified CXXC-type zinc finger family protein, which is encoded by the CXXC5 gene localised to the 5q31.3 chromosomal region. Previous studies revealed that CXXC5 is associated with various malignant tumours. The aim of the present study was to investigate the prognosis prediction...
Autores principales: | Fang, Lei, Wang, Yu, Gao, Yang, Chen, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006432/ https://www.ncbi.nlm.nih.gov/pubmed/29928427 http://dx.doi.org/10.3892/ol.2018.8647 |
Ejemplares similares
-
Overexpression of ECT2 is a strong poor prognostic factor in ER(+) breast cancer
por: Xiu, Yingying, et al.
Publicado: (2019) -
A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer
por: Good, Charly R., et al.
Publicado: (2017) -
A prelude to the proximity interaction mapping of CXXC5
por: Ayaz, Gamze, et al.
Publicado: (2021) -
Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma
por: Ito, Kan, et al.
Publicado: (2021) -
Inhibition of CXXC5 function reverses obesity‐related metabolic diseases
por: Seo, Seol Hwa, et al.
Publicado: (2022)